Intracept Basivertebral Nerve Ablation in St. Louis

Most low back pain gets blamed on a disc, a facet joint, or a nerve root. There is a fourth source that is often missed: the vertebral endplate — the thin layer of bone between the disc and the spine bone itself.

When an endplate is damaged and inflamed, it makes a deep, steady ache in the middle of the back. It acts unlike disc or facet pain. It is often worse with sitting and bending forward. It tends not to respond to treatments aimed at the parts around it. This is vertebrogenic pain. It has its own name because it has its own cause.

The endplate is supplied by the basivertebral nerve, which runs inside the spine bone itself. The Intracept procedure reaches that nerve through the bone and cuts it off with radiofrequency energy. Nothing is implanted. Nothing is fused. No disc or joint is touched.

This is one of the few pain sources you can see on a scan. That changes how we diagnose it.

Damaged, inflamed endplates leave a telltale mark on MRI called Modic changes, graded as Type 1 or Type 2. Seeing them at the painful levels is what marks a patient as having vertebrogenic pain, not pain from a nearby part. Every major trial of this procedure required Type 1 or Type 2 Modic changes to get in. That careful choice of patients is why those trials got the results they did.

So diagnosis joins the pain pattern — deep midline pain, worse sitting and bending, lasting more than six months — with an MRI read for endplate changes, not just for a slipped disc. Your MRI report may not mention Modic changes. That does not mean they are not there. It means the scan was read for a different question.

The evidence here is unusually strong for a pain procedure. So we will be exact about what was shown.

A prospective randomized controlled trial ran at 20 US sites. It enrolled 140 patients with low back pain of at least six months and Modic Type 1 or 2 changes between L3 and S1. They were randomized to basivertebral nerve ablation or to keep up standard care. At the prespecified interim analysis (a planned midway check), the treatment group showed superiority on every main and secondary outcome. An independent data committee recommended halting enrollment and offering the standard care group early crossover (a switch to treatment).

At three months, Oswestry Disability Index (ODI) scores improved by 25.3 points in the ablation group versus 4.4 points with standard care. That is an adjusted gap of 20.9 points. Pain scores improved by 3.46 versus 1.02. A clinically meaningful gain of at least 10 ODI points was reached by 74.5 percent of the ablation group versus 32.7 percent of the standard care group.

Follow-up of the treatment arm at 24 months found those gains held. Average disability improved 28.5 points from a starting score of 44.5. About 72 percent of patients said at least half their pain was gone, and 31 percent were pain-free at two years. No serious harm from the device or the procedure was reported through 24 months.

At the start, 36 percent of patients in that trial were taking opioids. At 24 months after ablation, 62 percent fewer patients were taking them.

That is the result this practice cares about most. The aim of pain procedures is not to stack a procedure on top of pills. It is to treat the source directly so the pills are no longer needed. A procedure that cuts opioid use two years later is doing what this practice exists to do.

The randomized trial above compared ablation with standard care. It was open label — patients knew which group they were in. That matters in procedure research, where the placebo response is large. An earlier, separate trial did use a sham control. Its treatment group kept its gains at two years. But the biggest and strongest comparison is against standard care, not against a convincing sham.

Industry money is also part of this research, including the published cost-effectiveness analysis. The randomized results come from many centers and were peer-reviewed. But you have a right to know who paid for the work when you weigh it.

And the entry rules are narrow on purpose. These results come from patients with confirmed Modic Type 1 or 2 changes at certain levels. They had already failed six months of conservative (non-surgical) care. The results say very little about someone whose endplates look normal. They say nothing at all about back pain in general. As with every procedure here, the honest truth is that picking the right patient does most of the work.

Intracept is a same-day procedure done under local anesthetic (numbing medicine) with live X-ray guidance. A small channel is made through the pedicle (a bony bridge at the back of the spine) into the spine bone. The basivertebral nerve is treated with radiofrequency energy. Then the tools come out. Nothing is left behind.

No sedation is used. You are awake the whole time, and most patients drive themselves home. It is the same plan we use for radiofrequency ablation elsewhere in the spine.

There are no activity restrictions afterward. Most patients return to normal activity, including work, within two to four hours. That is rare for a procedure that enters bone. It is possible because nothing is implanted and nothing is made unstable.

Relief is not instant. The procedure cuts off a nerve. It does not remove pressure on something. So improvement usually builds over the weeks after treatment, not on the day.

There is no national Medicare coverage determination for basivertebral nerve ablation. Several Medicare contractors publish their own local coverage determinations for it, each with its own rules. Private insurance policies vary. So we check coverage against your plan instead of assuming.

The rules that show up across policies match the trial entry rules. They also match good practice, no matter who pays. They are: low back pain lasting six months or more, written proof that conservative care failed, and Modic Type 1 or 2 endplate changes on MRI at the levels to be treated.

We do not publish prices. Call (314) 481-5000 and the office will check your coverage and tell you where you stand before anything is booked. Note that an authorization, if one is obtained, is not itself a guarantee of payment — plans reserve review of the claim after it is submitted.

Intracept is not a first step, and it is not a last resort. It treats one specific pain source, once that source has been found.

Conservative care comes first. If pain lasts, the question is which part is to blame. The answer decides the treatment. Facet radiofrequency ablation treats the facet joints, epidural steroid injection treats an irritated nerve root, SI joint fusion treats the sacroiliac joint, and MILD [Minimally Invasive Lumbar Decompression] treats stenosis from a thickened ligamentum flavum. Intracept treats the endplate. They are not swaps for one another. They answer different questions.

Because nothing is implanted or fused, Intracept keeps every later option open. Dr. Gurpreet Singh Padda, MD, MBA, MHP is a licensed physician and surgeon with surgical privileges, and the practice leads with the least invasive option that can do the job.

For more on the endplate as a pain source, see our article on basivertebral nerve ablation and vertebrogenic back pain.